RAG1 and neoplasm: This anti-tumour activity was completely abolished in Jα18−/− (deficient in iNKT cells), CD1d−/− (deficient in both NKT cell subsets) and RAG-1−/− (lack mature B and T lymphocytes) mice, strongly suggesting that iNKT cells were responsible for the anti-tumour effects (20).